Covington advised LifeArc on the deal. The deal consists of LifeArc monetization of a portion of its royalties relating to Keytruda® for $1.297 billion (approximately £1…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now